These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges. Goldner D; Lavine JE Gastroenterology; 2020 May; 158(7):1967-1983.e1. PubMed ID: 32201176 [TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic fatty liver disease as a multi-systemic disease. Fotbolcu H; Zorlu E World J Gastroenterol; 2016 Apr; 22(16):4079-90. PubMed ID: 27122660 [TBL] [Abstract][Full Text] [Related]
5. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Polyzos SA; Kountouras J; Mantzoros CS Metabolism; 2019 Mar; 92():82-97. PubMed ID: 30502373 [TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic Fatty Liver Disease in Children: Not a Small Matter. Conjeevaram Selvakumar PK; Kabbany MN; Alkhouri N Paediatr Drugs; 2018 Aug; 20(4):315-329. PubMed ID: 29740791 [TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic Fatty Liver Disease in Children. Mann JP; Valenti L; Scorletti E; Byrne CD; Nobili V Semin Liver Dis; 2018 Feb; 38(1):1-13. PubMed ID: 29471561 [TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic Fatty Liver Disease: Common Questions and Answers on Diagnosis and Management. Westfall E; Jeske R; Bader AR Am Fam Physician; 2020 Nov; 102(10):603-612. PubMed ID: 33179890 [TBL] [Abstract][Full Text] [Related]
9. Modern approach to the clinical management of non-alcoholic fatty liver disease. Del Ben M; Polimeni L; Baratta F; Pastori D; Loffredo L; Angelico F World J Gastroenterol; 2014 Jul; 20(26):8341-50. PubMed ID: 25024593 [TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic Fatty Liver Disease: An Important Consideration for Primary Care Providers in Hawai'i. Pattison RJ; Esteban JP; Sempokuya T; Kewcharoen J; Kalathil S; Kuwada SK Hawaii J Health Soc Welf; 2020 Jun; 79(6):180-186. PubMed ID: 32524096 [TBL] [Abstract][Full Text] [Related]
11. Emerging New Diagnostic Modalities and Therapies of Nonalcoholic Fatty Liver Disease. Lin CH; Kohli R Curr Gastroenterol Rep; 2020 Aug; 22(10):52. PubMed ID: 32814993 [TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies. Tomic D; Kemp WW; Roberts SK Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1103-1115. PubMed ID: 30113367 [TBL] [Abstract][Full Text] [Related]
13. [Advances in diagnosis and treatment of nonalcoholic fatty liver disease]. Zhu C; Zhou D; Fan J Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):81-4. PubMed ID: 26983471 [TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question. Streba LA; Vere CC; Rogoveanu I; Streba CT World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859 [TBL] [Abstract][Full Text] [Related]
16. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310 [TBL] [Abstract][Full Text] [Related]